Jefferies Raises Price Target on Bristol-Myers Squibb (BMY) Following 3Q
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Bristol-Myers Squibb Reports Third Quarter Financial Results
October 27, 2016 6:59 AM EDTIncreases Third Quarter Revenues 21% to $4.9 Billion Posts Third Quarter GAAP EPS of $0.72 and Non-GAAP EPS of $0.77 Achieves Key Regulatory Milestones for Opdivo Positive Advisory Opinion for the Treatment of Classical Hodgkin Lymphoma in Europe Application for Advanced Form of Bladder Cancer Accepted for Priority Review in U.S., Validated in Europe Announces Approval of $3 Billion Share Repurchase Authorization Announces Operating Model Evolution for Sustained Growth... More
